Hypokinesia

Hypokinesia is a clinical sign defined by a reduced amplitude of voluntary movement. It is often described as movements that are smaller or shorter in range than normal and may be accompanied by slight slow speed. Hypokinesia is conceptually distinct from bradykinesia (slowness of movement) and akinesia (difficulty initiating movement), though they frequently co-occur in Parkinsonian syndromes. Clinically, patients may show diminished arm swing, reduced facial expression (hypomimia), micrographia, and a pattern of small, shuffling steps, especially during gait.

Causes and pathophysiology: Hypokinesia most commonly arises from dysfunction in the basal ganglia-thalamocortical circuits, typically due to loss of dopaminergic neurons in the substantia nigra pars compacta as seen in Parkinsonian syndromes. Other etiologies include vascular parkinsonism, progressive supranuclear palsy, multiple system atrophy, and drug-induced extrapyramidal syndromes (such as dopamine antagonists). Metabolic or toxic conditions (for example Wilson disease) can also produce hypokinesia. The underlying mechanism generally involves reduced dopaminergic input to the striatum, which disrupts the direct pathway and increases inhibitory output to the thalamus, leading to diminished initiation and amplitude of voluntary movements.

Diagnosis: Diagnosis is clinical, based on history and examination. Rating scales such as the motor portion of the Unified Parkinson's Disease Rating Scale (UPDRS) may quantify severity. Neuroimaging is used to support the diagnosis or rule out mimics but is not diagnostic for hypokinesia itself; dopaminergic imaging may be helpful in uncertain cases.

Management: Treatment targets the underlying cause and aims to improve motor function. In Parkinsonian syndromes, dopaminergic therapy (e.g., levodopa) often improves hypokinesia; physical and occupational therapy are beneficial. In selected patients with advanced disease, deep brain stimulation may be considered. Avoidance of agents that worsen extrapyramidal symptoms is important.

Prognosis: The course and prognosis depend on the underlying condition; degenerative Parkinsonian syndromes typically involve progressive worsening of hypokinesia and related motor symptoms.